Eiger BioPharmaceuticals, Inc.
|
41.2 Million USD
|
96.372%
|
Nanobac Pharmaceuticals, Incorporated
|
4.12 Million USD
|
63.737%
|
SQZ Biotechnologies Company
|
27.47 Million USD
|
94.559%
|
Evofem Biosciences, Inc.
|
43.37 Million USD
|
96.554%
|
Santhera Pharmaceuticals Holding AG
|
29.76 Million USD
|
94.979%
|
Mesoblast Limited
|
118.7 Million USD
|
98.741%
|
Propanc Biopharma, Inc.
|
948.27 Thousand USD
|
-57.629%
|
Genus plc
|
233.1 Million USD
|
99.359%
|
VioQuest Pharmaceuticals, Inc.
|
2.93 Million USD
|
48.991%
|
CNBX Pharmaceuticals Inc.
|
1.34 Million USD
|
-11.251%
|
Marizyme, Inc.
|
18.71 Million USD
|
92.014%
|
ContraFect Corporation
|
2.88 Million USD
|
48.117%
|
Nymox Pharmaceutical Corporation
|
750 Thousand USD
|
-99.3%
|
PsyBio Therapeutics Corp.
|
135.48 Thousand USD
|
-1003.243%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
1.44 Million USD
|
-3.349%
|
Intellipharmaceutics International Inc.
|
2.32 Million USD
|
35.736%
|
AXIM Biotechnologies, Inc.
|
5.65 Million USD
|
73.583%
|
MultiCell Technologies, Inc.
|
202.58 USD
|
-737757.143%
|
Accustem Sciences Inc.
|
- USD
|
-Infinity%
|
RVL Pharmaceuticals plc
|
57.48 Million USD
|
97.4%
|
Q BioMed Inc.
|
4.1 Million USD
|
63.631%
|
Emmaus Life Sciences, Inc.
|
33.1 Million USD
|
95.484%
|
Neon Bloom, Inc.
|
630.07 Thousand USD
|
-137.233%
|
Mosaic ImmunoEngineering Inc.
|
1.22 Million USD
|
-21.687%
|
Biomind Labs Inc.
|
735.54 Thousand USD
|
-103.218%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
-Infinity%
|
Pharming Group N.V.
|
171.54 Million USD
|
99.129%
|
Oncotelic Therapeutics, Inc.
|
12.99 Million USD
|
88.499%
|
Skye Bioscience, Inc.
|
4.61 Million USD
|
67.613%
|
Therapeutic Solutions International, Inc.
|
888.06 Thousand USD
|
-68.316%
|
THC Farmaceuticals, Inc.
|
141.51 Thousand USD
|
-956.227%
|
Arch Therapeutics, Inc.
|
5.87 Million USD
|
74.54%
|
IMV Inc.
|
28.88 Million USD
|
94.825%
|
Acro Biomedical Co., Ltd.
|
25.71 Thousand USD
|
-5711.855%
|
Curative Biotechnology, Inc.
|
2.25 Million USD
|
33.813%
|
GB Sciences, Inc.
|
1.75 Million USD
|
15.038%
|
Alpha Cognition Inc.
|
1.22 Million USD
|
-22.483%
|
HST Global, Inc.
|
98.31 Thousand USD
|
-1420.307%
|
CSL Limited
|
12.18 Billion USD
|
99.988%
|
Halberd Corporation
|
150 Thousand USD
|
-896.501%
|
Enzolytics Inc.
|
996.33 Thousand USD
|
-50.024%
|
Resverlogix Corp.
|
6.49 Million USD
|
76.972%
|
Affymax, Inc.
|
- USD
|
-Infinity%
|
SYBLEU INC
|
477.5 Thousand USD
|
-213.037%
|
Nuo Therapeutics, Inc.
|
255.59 Thousand USD
|
-484.819%
|
argenx SE
|
20 Million USD
|
92.526%
|
MetaStat, Inc.
|
- USD
|
-Infinity%
|
Northwest Biotherapeutics, Inc.
|
45.56 Million USD
|
96.719%
|
Enzon Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Arno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
RespireRx Pharmaceuticals Inc.
|
2.7 Million USD
|
44.817%
|
GeneThera, Inc.
|
- USD
|
-Infinity%
|
Inhibitor Therapeutics, Inc.
|
- USD
|
-Infinity%
|
AVAX Technologies, Inc.
|
- USD
|
-Infinity%
|
Zenith Capital Corp.
|
10.22 Thousand USD
|
-14518.592%
|
Genscript Biotech Corporation
|
417.73 Million USD
|
99.642%
|
Ember Therapeutics, Inc.
|
200.61 Thousand USD
|
-645.081%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sigyn Therapeutics, Inc.
|
2.39 Million USD
|
37.66%
|
WPD Pharmaceuticals Inc.
|
229.29 Thousand USD
|
-551.901%
|
American Oriental Bioengineering, Inc.
|
67.64 Million USD
|
97.79%
|
Provectus Biopharmaceuticals, Inc.
|
3.02 Million USD
|
50.606%
|
Adynxx, Inc.
|
- USD
|
-Infinity%
|
Helix BioMedix, Inc.
|
- USD
|
-Infinity%
|
GlobeStar Therapeutics Corporation
|
359.71 Thousand USD
|
-315.543%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
-Infinity%
|
Capstone Therapeutics Corp.
|
20.32 Million USD
|
92.647%
|
Cotinga Pharmaceuticals Inc.
|
148.65 Thousand USD
|
-905.524%
|
BioStem Technologies, Inc.
|
4.71 Million USD
|
68.274%
|
ONE Bio Corp.
|
19.71 Million USD
|
92.418%
|
Reve Technologies, Inc.
|
250.18 Thousand USD
|
-497.465%
|
Burzynski Research Institute, Inc.
|
- USD
|
-Infinity%
|
Wesana Health Holdings Inc.
|
248.72 Thousand USD
|
-500.977%
|
Agentix Corp.
|
50 Thousand USD
|
-2889.502%
|
LadRx Corporation
|
33.6 Thousand USD
|
-4347.869%
|
Cell Source, Inc.
|
9.25 Million USD
|
83.848%
|
ProtoKinetix, Incorporated
|
- USD
|
-Infinity%
|
Regen BioPharma, Inc.
|
756.2 Thousand USD
|
-97.665%
|
Regen BioPharma, Inc.
|
756.2 Thousand USD
|
-97.665%
|
NovAccess Global Inc.
|
2.19 Million USD
|
32.053%
|
Endonovo Therapeutics, Inc.
|
7.07 Million USD
|
78.866%
|
Itoco Inc.
|
228.37 Thousand USD
|
-554.51%
|
Rasna Therapeutics, Inc.
|
210.97 Thousand USD
|
-608.497%
|
Pathfinder Cell Therapy, Inc.
|
4.98 Million USD
|
70.003%
|
Kadimastem Ltd
|
891.22 Thousand USD
|
-67.719%
|
Oncology Pharma Inc.
|
- USD
|
-Infinity%
|
Institute of Biomedical Research Corp.
|
401.84 Thousand USD
|
-271.968%
|
CytoDyn Inc.
|
30.07 Million USD
|
95.03%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
NDT Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Mobile Lads Corp.
|
484.28 Thousand USD
|
-208.652%
|
NanoSphere Health Sciences Inc.
|
- USD
|
-Infinity%
|
Qrons Inc.
|
351.84 Thousand USD
|
-324.83%
|
Alseres Pharmaceuticals, Inc.
|
7.81 Million USD
|
80.885%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
-Infinity%
|
Nascent Biotech, Inc.
|
122.5 Thousand USD
|
-1120.205%
|
Rebus Holdings, Inc.
|
310 Thousand USD
|
-382.178%
|
ImmunoCellular Therapeutics, Ltd.
|
4.73 Million USD
|
68.434%
|
International Stem Cell Corporation
|
4.17 Million USD
|
64.223%
|
Bioxytran, Inc.
|
1.92 Million USD
|
22.351%
|
GlobeImmune, Inc.
|
- USD
|
-Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
-Infinity%
|
ProText Mobility, Inc.
|
62.41 Thousand USD
|
-2294.935%
|
Cardax, Inc.
|
- USD
|
-Infinity%
|
VG Life Sciences Inc.
|
2.18 Million USD
|
31.462%
|
Kaleido Biosciences, Inc.
|
- USD
|
-Infinity%
|
Advaxis, Inc.
|
8.31 Million USD
|
82.026%
|
Adhera Therapeutics, Inc.
|
8.58 Million USD
|
82.589%
|
RenovaCare, Inc.
|
- USD
|
-Infinity%
|
Regnum Corp.
|
1.55 Million USD
|
3.904%
|
Innovation Pharmaceuticals Inc.
|
268 Thousand USD
|
-457.743%
|
Neutra Corp.
|
54.15 Thousand USD
|
-2660.084%
|
Windtree Therapeutics, Inc.
|
1.83 Million USD
|
18.32%
|
PureTech Health plc
|
25.51 Million USD
|
94.141%
|
Coeptis Therapeutics, Inc.
|
1.22 Million USD
|
-22.098%
|
IXICO plc
|
472.02 Thousand USD
|
-216.669%
|
IntelGenx Technologies Corp.
|
15.5 Million USD
|
90.357%
|
Gelesis Holdings, Inc.
|
62.26 Million USD
|
97.599%
|
CSL Limited
|
12.18 Billion USD
|
99.988%
|
Cellectis S.A.
|
92.77 Million USD
|
98.389%
|